23 Jul RoosterBio
Matt Drew, Vice President, Sales and Marketing
At RoosterBio, we are pioneers in radically simplifying the use of adult human mesenchymal stem/stromal cells to propel the commercialization of regenerative technologies. By enabling living cells to become more affordable at the lowest cost per million cells with industry-leading supporting quality documentation, we make MSCs easier to access and much simpler to incorporate into product development efforts, leading to a rapid acceleration in products coming to market that incorporate these technologies. RoosterBio is driving the transition of MSCs from a scarce resource into an abundant resource where billions are the new millions. By increasing their availability and decreasing the complexity required to incorporate them into products, we are ushering in a new era of productivity and standardization in regenerative medicine. Our innovative translation-friendly products are high volume, affordable, and well-characterized hMSCs paired with highly engineered media systems that ease the regulatory pathway and accelerate speed to market.